Alto Neuroscience
ANRO • NYSE
Alto Neuroscience is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Amit Etkin, with a market cap of $715.6M.
Market Cap$715.6M
Employees63.0
CEOAmit Etkin
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Alto Neuroscience FAQ
Common questions about Alto Neuroscience
Alto Neuroscience is scheduled to report earnings for Q1 2026 on May 13, 2026.
Alto Neuroscience has approximately 63 employees.